Patrik Renblad
Director of Finance/CFO at CANTARGIA AB
Patrik Renblad active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CANTARGIA AB | Director of Finance/CFO | 2023-06-14 | - |
Career history of Patrik Renblad
Former positions of Patrik Renblad
| Companies | Position | Start | End |
|---|---|---|---|
| SYNACT PHARMA AB | Director of Finance/CFO | 2022-01-06 | 2023-05-14 |
| Corporate Officer/Principal | 2021-07-31 | 2022-01-06 | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Training of Patrik Renblad
| University of Lund | Graduate Degree |
Statistics
International
| Sweden | 4 |
| Denmark | 2 |
Operational
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SYNACT PHARMA AB | Health Technology |
| CANTARGIA AB | Health Technology |
| Private companies | 1 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Patrik Renblad
- Experience
